HCV treatment among male inmates in NSW: Determining social capital indicators for accessing treatment and improvements in QALYs post-treatment

新南威尔士州男性囚犯的丙肝治疗：确定获得治疗的社会资本指标以及治疗后 QALY 的改善

• 批准号: nhmrc : 1075727
• 负责人: Dr Lise Lafferty
• 金额: $ 4.6万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/hcv-treatment-male-post-treatment/455692
• 关键词: HCV; treatment; among; male; inmates

The HCV treatment among male inmates in NSW study will focus on identifying and measuring the social capital of inmates in custody with hepatitis C virus (HCV) in NSW correctional centres. A comparison of the social capital experienced by Aboriginal and non-Aboriginal men will be conducted. A cost-utility analysis of HCV treatment will also be conducted. Changes in social capital and quality-adjusted life years following treatment will be measured to identify any gains achieved following completion of treatment.

新南威尔士州男性囚犯中的丙型肝炎治疗研究将侧重于确定和衡量新南威尔士州惩教中心在押的丙型肝炎病毒（HCV）囚犯的社会资本。将对土著男子和非土著男子的社会资本进行比较。还将进行HCV治疗的成本效用分析。将测量治疗后社会资本和质量调整生命年的变化，以确定完成治疗后取得的任何收益。